Pathway Financial Advisers’s Marvell Technology MRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.97M Sell
16,671
-347
-2% -$69.6K 1.25% 21
2026
Q1
$1.69M Sell
17,018
-94
-0.5% -$7.89K 0.48% 73
2025
Q4
$1.45M Sell
17,112
-142
-0.8% -$12.4K 0.42% 81
2025
Q3
$1.45M Buy
17,254
+2,021
+13% +$149K 0.42% 78
2025
Q2
$1.18M Buy
15,233
+338
+2% +$21.1K 0.38% 83
2025
Q1
$917K Sell
14,895
-342
-2% -$33.2K 0.31% 94
2024
Q4
$1.68M Buy
15,237
+91
+0.6% +$8.45K 0.56% 60
2024
Q3
$1.09M Buy
15,146
+545
+4% +$37.6K 0.49% 64
2024
Q2
$1.02M Buy
14,601
+169
+1% +$11.8K 0.37% 86
2024
Q1
$1.02M Buy
14,432
+310
+2% +$21.2K 0.37% 85
2023
Q4
$852K Buy
14,122
+177
+1% +$9.56K 0.32% 90
2023
Q3
$755K Buy
+13,945
New +$823K 0.31% 87
2023
Q1
$503K Buy
11,614
+3,239
+39% +$136K 0.2% 117
2022
Q4
$310K Buy
+8,375
New +$342K 0.13% 137

Other funds holding MRVL

Pathway Financial Advisers's MRVL Position: Q2 2026 in Review

Pathway Financial Advisers reduced its Marvell Technology (MRVL) stake by 2% in Q2 2026, selling an estimated $69.6K and leaving 16,671 shares worth $4.97M. The position accounts for 1.25% of the portfolio, ranked #21.

Pathway Financial Advisers first reported a position in MRVL in Q4 2022 and has held it in 14 quarters since. 971 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.

  • Pathway Financial Advisers held 16,671 shares of Marvell Technology worth $4.97M as of Q2 2026.
  • Pathway Financial Advisers sold 347 Marvell Technology shares in Q2 2026, an estimated $69.6K.
  • Marvell Technology made up 1.25% of Pathway Financial Advisers's portfolio in Q2 2026, its #21 holding.
  • Pathway Financial Advisers first reported a position in Marvell Technology in Q4 2022 and has held it in 14 quarters since.
  • 971 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.

Based on Pathway Financial Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.